FIGO staging for carcinosarcoma: can the revised staging system predict overall survival?

Area of Science:

• Gynecologic Oncology
• Surgical Pathology
• Cancer Staging Systems

Background:

• Uterine carcinosarcoma is an aggressive malignancy with a poor prognosis.
• Accurate staging is crucial for predicting patient survival and guiding treatment.
• The International Federation of Gynecology and Obstetrics (FIGO) revised its staging system in 2009.

Purpose of the Study:

• To compare the predictive accuracy of the 1988 FIGO staging system versus the revised 2009 FIGO staging system for uterine carcinosarcoma.
• To determine if the revised staging system more accurately reflects actual patient survival outcomes.

Main Methods:

• Retrospective analysis of 112 uterine carcinosarcoma patients diagnosed between 1988 and 2010.
• Patients were staged using both the 1988 and 2009 FIGO criteria.
• Time-dependent receiver operating characteristic (ROC) curves and Kaplan-Meier survival analysis were used for comparison.

Main Results:

• The revised 2009 FIGO staging system showed a slightly lower area under the ROC curve (0.65) compared to the former system (0.67).
• Four patients (3.6%) were downstaged under the revised broad staging criteria.
• The median survival time post-diagnosis was 610 days.

Conclusions:

• The revised 2009 FIGO staging system for uterine carcinosarcoma does not offer improved survival prediction over the previous system.
• Uterine carcinosarcoma demonstrates an overall poor prognosis.
• There is a need for improved prognostic indicators for this disease.